Drug Shortage Report for TEGRETOL

Last updated on 2020-04-17 History
Report ID 101771
Drug Identification Number 00010405
Brand name TEGRETOL 200MG
Common or Proper name TEGRETOL 200MG TABS 100'S
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100'S
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-12-23
Actual start date 2019-12-24
Estimated end date 2020-04-03
Actual end date 2020-04-03
Shortage status Resolved
Updated date 2020-04-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2020-04-17 French Compare
v15 2020-04-17 English Compare
v14 2020-03-27 French Compare
v13 2020-03-27 English Compare
v12 2020-03-20 French Compare
v11 2020-03-20 English Compare
v10 2020-03-09 French Compare
v9 2020-03-09 English Compare
v8 2020-01-10 French Compare
v7 2020-01-10 English Compare
v6 2019-12-25 English Compare
v5 2019-12-24 French Compare
v4 2019-12-24 English Compare
v3 2019-12-24 English Compare
v2 2019-12-19 French Compare
v1 2019-12-19 English Compare

Showing 1 to 16 of 16